Evidence map›Paper›PMID 33109198›Full record

ArticleBMC complementary medicine and therapies2020

Asparagus cochinchinensis extract ameliorates menopausal depression in ovariectomized rats under chronic unpredictable mild stress.

Hye Ryeong Kim, Young-Ju Lee, Tae-Wan Kim, Ri-Na Lim, Dae Youn Hwang, Jeffrey J Moffat, Soonil Kim, Joung-Wook Seo, Minhan Ka

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Nutrition research and practice · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Effect of a Standardized Extract ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Frontiers in pharmacology · 2022
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Hye Ryeong KimPharmacology and Drug Abuse Research Group, Research Center for Convergence Toxicology, Korea Institute of Toxicology, KRICT, Daejeon, 34114, Republic of Korea.
Young-Ju LeePharmacology and Drug Abuse Research Group, Research Center for Convergence Toxicology, Korea Institute of Toxicology, KRICT, Daejeon, 34114, Republic of Korea.
Tae-Wan KimPharmacology and Drug Abuse Research Group, Research Center for Convergence Toxicology, Korea Institute of Toxicology, KRICT, Daejeon, 34114, Republic of Korea.
Ri-Na LimPharmacology and Drug Abuse Research Group, Research Center for Convergence Toxicology, Korea Institute of Toxicology, KRICT, Daejeon, 34114, Republic of Korea.
Dae Youn HwangDepartment of Biomaterials Science, College of Natural Resources and Life Science/Life and Industry Convergence Research Institute, Pusan National University, Miryang, 50463, Republic of Korea.
Jeffrey J MoffatDepartment of Neurology, University of California, San Francisco, San Francisco, CA, 94143, USA.
Soonil KimOlmanfood Co., Ltd, Seoul, 03709, Republic of Korea.
Joung-Wook SeoPharmacology and Drug Abuse Research Group, Research Center for Convergence Toxicology, Korea Institute of Toxicology, KRICT, Daejeon, 34114, Republic of Korea. jwseo@kitox.re.kr.
Minhan KaPharmacology and Drug Abuse Research Group, Research Center for Convergence Toxicology, Korea Institute of Toxicology, KRICT, Daejeon, 34114, Republic of Korea. minhan.ka@kitox.re.kr.ORCID http://orcid.org/0000-0003-2336-4184
Korea Institute of Toxicology · KRPusan National University · KRUniversity of California, San Francisco · US

Funding

Korea Institute of Toxicology KK-1811-03Korea Institute of Toxicology KK-1908-03Korea Technology and Information Promotion Agency for SMEs C0541691National Research Foundation of Korea NRF-2019R1A2C1009006
6 · The paper itself

Abstract

backgroundDepression is a serious and common psychiatric disorder generally affecting more women than men. A woman's risk of developing depression increases steadily with age, and higher incidence is associated with the onset of menopause. Here we evaluated the antidepressant properties of Asparagus cochinchinensis (AC) extract and investigated its underlying mechanisms in a rat menopausal depression model.

methodsTo model this menopausal depression, we induced a menopause-like state in rats via ovariectomy and exposed them to chronic unpredictable mild stress (CUMS) for 6 weeks, which promotes the development of depression-like symptoms. During the final 4 weeks of CUMS, rats were treated with either AC extract (1000 or 2000 mg/kg, PO), which has been reported to provide antidepressant effects, or with the tricyclic antidepressant imipramine (10 mg/kg, IP).

resultsWe report that CUMS promotes depression-like behavior and significantly increases serum corticosterone and inflammatory cytokine levels in the serum of ovariectomized (OVX) rats. We also found that CUMS decreases the expression of brain-derived neurotrophic factor (BDNF) and its primary receptor, tropomyosin receptor kinase B (TrkB), in OVX rats, and treatment with AC extract rescues both BDNF and TrkB expression levels.

conclusionThese results suggest that AC extract exerts antidepressant effects, possibly via modulation of the BDNF-TrkB pathway, in a rat model of menopausal depression.

Indexed as

Asparagus PlantMenopauseAnimalsAntidepressive AgentsChinaDepressionDisease Models, AnimalFemaleOvariectomyPlant ExtractsPlant RootsRatsRats, WistarStress, PsychologicalAntidepressive AgentsPlant ExtractsAsparagus cochinchinensisBDNF-TrkB signalingChronic mild stressCorticosteroneDepression-like behaviorInflammatory cytokinesMenopausal depressionOvariectomized rats

Identifiers

PMID33109198
PMCPMC7590795
OpenAlexW3096089377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.